CERTARA INC. - COMMON STOCK
13.84
11-February-25 14:00:36
15 minutes delayed
Stocks
-0.16
-1.14%
Today's range
13.78 - 14.23
ISIN
N/A
Source
NASDAQ
-
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
16 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
Certara Reports Fourth Quarter 2023 Financial Results
29 Feb 2024 16:10:01 By Nasdaq GlobeNewswire
-
01 Feb 2024 16:30:00 By Nasdaq GlobeNewswire
-
13 Dec 2023 16:30:00 By Nasdaq GlobeNewswire
-
21 Nov 2023 16:30:00 By Nasdaq GlobeNewswire
-
Certara Reports Third Quarter 2023 Financial Results
08 Nov 2023 16:10:01 By Nasdaq GlobeNewswire
-
11 Oct 2023 16:15:00 By Nasdaq GlobeNewswire
-
19 Sep 2023 08:15:00 By Nasdaq GlobeNewswire
-
Certara to Participate in Upcoming Investor Conferences
29 Aug 2023 16:15:00 By Nasdaq GlobeNewswire
-
Certara Simcyp™ Group Awarded Two New Grants from US FDA
29 Aug 2023 08:15:00 By Nasdaq GlobeNewswire
-
Certara Reports Second Quarter 2023 Financial Results
09 Aug 2023 16:15:01 By Nasdaq GlobeNewswire
-
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
13 Jul 2023 16:30:00 By Nasdaq GlobeNewswire
-
Certara to Participate in the Jefferies Global Healthcare Conference
02 Jun 2023 16:15:00 By Nasdaq GlobeNewswire
-
Certara Reports First Quarter 2023 Financial Results
08 May 2023 16:15:00 By Nasdaq GlobeNewswire
-
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
27 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
10 Apr 2023 16:30:00 By Nasdaq GlobeNewswire
-
A.I. Coming to Certara’s D360 Scientific Informatics Software
09 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
07 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
Certara Reports Fourth Quarter and Full Year 2022 Financial Results
01 Mar 2023 16:16:01 By Nasdaq GlobeNewswire
-
Certara Announces Transition Plan for Chief Financial Officer
01 Mar 2023 16:15:00 By Nasdaq GlobeNewswire